Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Mesoporous Silica Nanoparticles As a Versatile Nanocarrier for Cancer Treatment: A Review Publisher



Taleghani AS1 ; Nakhjiri AT1 ; Khakzad MJ2 ; Rezayat SM3, 4, 5 ; Ebrahimnejad P6, 7 ; Heydarinasab A1 ; Akbarzadeh A8 ; Marjani A9, 10
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Petroleum and Chemical Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran
  2. 2. Department of Materials Engineering, Shahrood Branch, Islamic Azad University, Shahrood, Iran
  3. 3. Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Toxicology–Pharmacology, Faculty of Pharmacy, Pharmaceutical Science Branch, Islamic Azad University (IAUPS), Tehran, Iran
  6. 6. Pharmaceutical Science Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran
  7. 7. Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
  8. 8. Department of Nano-biotechnology Pilot, Pasteur Institute of Iran, Tehran, Iran
  9. 9. Department for Management of Science and Technology Development, Ton Duc Thang University, Ho Chi Minh City, Viet Nam
  10. 10. Faculty of Applied Sciences, Ton Duc Thang University, Ho Chi Minh City, Viet Nam

Source: Journal of Molecular Liquids Published:2021


Abstract

Curing cancer has drastically improved in recent decades, but it is essential to find more effective and specific treatments. Radiotherapy and chemotherapy can cause serious side effects and tumor resection surgery may not always be possible. In order to prevail these problems, it is required to find novel therapies to reduce side effects. Application of drug delivery nanovehicles is a promising strategy. Mesoporous silica nanoparticles (MSNPs), amongst various vehicles, have gained tremendous attentions owing to their excellent characteristics including ease of surface modification, improved biocompatibility, chemical and thermal stability, tunable pore diameters and great surface areas. MSNPs possess ordered structure which is very appropriate for packing high amount of drug moieties. Moreover, MSNPs can be tailored by several stimuli sensitive gatekeepers for releasing their cargos. Drug delivery from MSNPs can be controlled by passive targeting of cancer tissues through enhanced permeability and retention (EPR) effect or by active targeting with surface modification of MSNPs using various ligands. This review article outlines the MSNPs synthesis, focuses on the recent progression on the use of MSNPs for stimuli responsive and targeted drug delivery for cancer treatment, and discusses the endosomal escape of MSNPs. Although MSNPs are known for being versatile tools for safer and more efficient cancer treatment, more translational research is needed to study their multifunctional ability in clinical trials. © 2021 Elsevier B.V.
Other Related Docs
10. Nano-Particles’ Benefits for Colon Cancer Effective Therapy: A Review of Recent Advancements and Clinical Trials, International Journal of Polymeric Materials and Polymeric Biomaterials (2024)
11. Encapsulation: Controlled Drug Delivery, Principles of Biomaterials Encapsulation: Volume 2 (2023)
20. A Review on Liposome-Based Therapeutic Approaches Against Malignant Melanoma, International Journal of Pharmaceutics (2021)
26. Zeolites for Theranostic Applications, Journal of Materials Chemistry B (2020)
31. Folate-Conjugated Gold Nanoparticle As a New Nanoplatform for Targeted Cancer Therapy, Journal of Cancer Research and Clinical Oncology (2016)
36. Commercial and Regulatory Challenges in Cancer Nanomedicine, Functionalized Nanomaterials for Cancer Research: Applications in Treatments# Tools and Devices (2024)
38. Recent Advances in Plga-Based Nanofibers As Anticancer Drug Delivery Systems, Journal of Drug Delivery Science and Technology (2023)
42. Rgd-Engineered Nanoparticles As an Innovative Drug Delivery System in Cancer Therapy, Journal of Drug Delivery Science and Technology (2023)
46. Anti-Cancer Drug Delivery Using Carbohydrate-Based Polymers, Current Pharmaceutical Design (2017)
50. Smart External Stimulus-Responsive Nanocarriers for Drug and Gene Delivery, Smart External Stimulus-Responsive Nanocarriers for Drug and Gene Delivery (2015)